<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04214782</url>
  </required_header>
  <id_info>
    <org_study_id>2019-TJ-OVAB</org_study_id>
    <nct_id>NCT04214782</nct_id>
  </id_info>
  <brief_title>Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm</brief_title>
  <official_title>Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hubei Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qilu Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangyang Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First People's Hospital of Jingzhou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ovarian cancer is relatively rare but fatal with an annual incidence rate of 11.8 per 100 000
      and a high mortality‐to‐incidence ratio of &gt;0.6. The modest diagnostic accuracy of TVU has
      risen some concerns about the over-treatment.Now, with the development of artificial
      intelligence (AI), we may have a better chance to interpret TVU imagines with high
      efficiency, reproducibility and accuracy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>diagnostic accuracy</measure>
    <time_frame>2 years</time_frame>
    <description>diagnostic accuracy comparsion between Transvaginal Ultrasound diagnosis with and without Artificial Intelligence algorithm for ovarian cancer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time cost for Transvaginal Ultrasound image interpretation</measure>
    <time_frame>2 years</time_frame>
    <description>time cost for radiologists to interpret Transvaginal Ultrasound images</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Transvaginal Ultrasound diagnosis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>radiologists interpretTransvaginal Ultrasound images without the help of Artificial Intelligence (AI) algorithm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AI enabled Transvaginal Ultrasound diagnosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>radiologists interpretTransvaginal Ultrasound images with the help of Artificial Intelligence algorithm</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm</intervention_name>
    <description>AI Enabled Transvaginal Ultrasound diagnosis for ovarian cancer</description>
    <arm_group_label>AI enabled Transvaginal Ultrasound diagnosis</arm_group_label>
    <other_name>AI Enabled Transvaginal Ultrasound diagnosis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women scheduled for Transvaginal Ultrasound examination for adnexal lesions;

          -  Women aged over 18 years old;

          -  Women willing to participant in this study evidenced by signing the informed consent.

        Exclusion Criteria:

          -  Women without adnexa for any reasons at the time of Transvaginal Ultrasound
             examination, including but not limited to receiving surgical removal for adnexa;

          -  Women with a pathologic diagnosis of ovarian cancer before the Transvaginal Ultrasound
             examination;

          -  Women with mental abnormal;

          -  Women did not cooperate or participate in other clinical trials;

          -  Pregnant or lactating women.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qinglei Gao, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Tongji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qinglei Gao, MD, PhD</last_name>
    <phone>13871127473</phone>
    <phone_ext>13871127473</phone_ext>
    <email>qingleigao@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ding Ma, MD, PhD</last_name>
    <phone>13886090620</phone>
    <phone_ext>13886090620</phone_ext>
    <email>dingma424@126.com</email>
  </overall_contact_backup>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 28, 2019</study_first_submitted>
  <study_first_submitted_qc>December 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 2, 2020</study_first_posted>
  <last_update_submitted>December 28, 2019</last_update_submitted>
  <last_update_submitted_qc>December 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Qinglei Gao</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>contact Prof. Gao for detialed study protocol or data after study completed by e-mail</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>6 monthes after study completed</ipd_time_frame>
    <ipd_access_criteria>all investigators in this study field can contact Prof. Gao for access by e-mail</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

